Are you looking for "Bevacizumab Eligibility Hypertension"? If so, you came to the right place! This web portal was produced to provide you with information and links to the most useful online resources.

Search Yahoo for: Bevacizumab Eligibility Hypertension

Get MSN search results for Bevacizumab Eligibility Hypertension in RSS format.

Cancer Clinical Trials at Holy Family Memorial
...or without bevacizumab or bevacizumab alone.  To define toxicity of these regimens. Eligibility ... No brain metastases.  Hypertension must be...

National Cancer Institute - Clinical Trials (PDQ®)
Alternate Title. Bevacizumab in Treating Patients With Kaposi's Sarcoma ... No uncontrolled hypertension (systolic blood pressure must be < 160 mm...

Mesothelioma/Asbestos Update - Chemotherapy With or Without
With or Without Bevacizumab in Treating Patients ... within 16 months. ELIGIBILITY. Ages Eligible for ... past 6 months No uncontrolled hypertension...

Clinical Trial: Bevacizumab With or Without Thalidomide in Treating
Bevacizumab With or Without Thalidomide in ... within 2.5 years. Eligibility ... Ages Eligible for ... No uncontrolled hypertension. No history of...

Clinical Trial: Doxorubicin and Bevacizumab in Treating Patients
Doxorubicin and Bevacizumab in Treating Patients With ... 13.3 months. Eligibility ... Ages Eligible for ... No uncontrolled hypertension. No...

National Cancer Institute - Clinical Trials (PDQ®)
Study of Interferon alfa-2b With or Without Bevacizumab in Patients With ... No uncontrolled hypertension defined as blood pressure ≥160 mm Hg...

Clinical Trial: Combination Chemotherapy With or Without Bevacizumab
With or Without Bevacizumab in Treating Patients ... within 16 months. Eligibility ... Ages Eligible ... No uncontrolled hypertension. No...

Bevacizumab in the Treatment of Breast Cancer: Rationale and Current
...profile of bevacizumab differs from that of cytotoxic chemotherapy and includes hypertension ... Eligibility included resistance to both...

Clinical Study: 03-C-0110, Phase II Study of Intravenous Recombinant
Eligibility Criteria: INCLUSION CRITERIA: ... disease such as uncontrolled hypertension (with ... or humanized antibodies. Previous bevacizumab. Any...

Clinical Study: 01-C-0173, A Pilot Study to Evaluate Angiogenesis
...after Treatment with Bevacizumab (Anti-VEGF ... Eligibility Criteria: INCLUSION CRITERIA: ... Uncontrolled hypertension (sustained systolic blood...